Archives
-
TCAIM-Mediated Regulation of OGDH: A Mitochondrial Metabolis
2026-06-03
Wang et al. (2025) uncover a unique post-translational control mechanism in mitochondrial metabolism, showing that the cochaperone TCAIM selectively binds and reduces OGDH protein levels. This discovery advances our understanding of mitochondrial proteostasis and its implications for cellular energy regulation.
-
LKB1-Mediated Telomerase Inhibition and Senescence in Lung A
2026-06-03
This study uncovers how LKB1 suppresses telomerase activity and induces cellular senescence in lung adenocarcinoma by modulating histone lactylation and Sp1-dependent transcription. The mechanistic insights broaden our understanding of tumor suppression and inform new directions for targeted cancer therapies.
-
Naftifine HCl: Applied Antifungal Workflows & Research Insig
2026-06-02
Naftifine HCl stands out as a high-purity allylamine antifungal agent that empowers precise sterol biosynthesis studies and advanced topical antifungal models. This article delivers actionable workflows, troubleshooting tips, and translates cutting-edge signaling research into optimized experimental designs for mycology labs.
-
SIRT1-Mediated Deacetylation of Plk2 Regulates Centriole Dup
2026-06-02
This study reveals how SIRT1, a class III histone deacetylase, temporally controls centriole duplication by deacetylating and destabilizing the centrosomal protein Plk2. The findings offer new mechanistic insights into the intersection of epigenetic regulation and centrosome biology, with implications for understanding chromosomal instability in cancer.
-
ATS-9R: Transforming Adipocyte-Targeted Gene Therapy Strateg
2026-06-01
Discover how ATS-9R (Adipocyte-targeting sequence-9-arginine) redefines targeted gene delivery to white adipose tissue, enabling precise modulation of obesity-linked pathways. Unpack the mechanistic depth, assay design considerations, and translational impact of this innovative non-viral fusion oligopeptide.
-
GSK J4 HCl (SKU A4190): Reliable JMJD3 Inhibition in Cell As
2026-06-01
This article delivers scenario-driven guidance for researchers employing GSK J4 HCl (SKU A4190), a potent JMJD3 inhibitor, to address common challenges in cell viability and inflammation assays. Drawing on published data and best practices, it highlights how APExBIO’s formulation ensures reproducibility and confidence in epigenetic regulation research workflows.
-
Single-Base 5hmC Mapping Reveals Epigenetic Control in Rice
2026-05-31
This study delivers the first high-resolution, single-base map of 5-hydroxymethylcytosine (5hmC) in rice, revealing its dynamic and genomic context-dependent roles during drought adaptation. The findings offer critical insight into plant epigenetics, highlighting how differential 5hmC localization modulates gene expression under environmental stress.
-
Lopinavir (ABT-378): Applied HIV Protease Inhibition Workflo
2026-05-30
Lopinavir (ABT-378) stands out for its robust HIV protease inhibition, nanomolar potency in serum-rich assays, and proven reliability in both HIV and rapid-response antiviral research. Explore protocol parameters, troubleshooting guidance, and cross-domain applications that empower researchers to achieve reproducible, high-sensitivity results.
-
Murine RNase Inhibitor: Precision RNA Degradation Prevention
2026-05-29
APExBIO’s Murine RNase Inhibitor offers robust, oxidation-resistant protection for sensitive RNA workflows, outperforming traditional RNase A inhibitors in low-reducing environments. Its unique recombinant design delivers reproducible RNA integrity in applications ranging from cgSHAPE-seq to real-time RT-PCR and cDNA synthesis.
-
Uridine, Trisodium Salt: Reliable RNA Biosynthesis in Cell A
2026-05-29
This article details how Uridine, Trisodium Salt (SKU B1473) addresses crucial lab challenges in RNA biosynthesis, cell viability, and vascular research. Drawing on peer-reviewed protocols and the latest genome engineering data, it guides researchers through evidence-backed workflow decisions, focusing on reproducibility and scientific rigor.
-
D-Luciferin Potassium Salt: Transforming Bioluminescence Ima
2026-05-28
D-Luciferin (potassium salt) unlocks sensitive, real-time in vivo bioluminescence imaging and quantitative luciferase-based assays, thanks to its superior water solubility and purity. Discover how this APExBIO reagent streamlines tumor cell tracking, ATP dynamics, and reporter workflows while providing actionable troubleshooting strategies.
-
Tumor-Targeted PAD4 Inhibitors Disrupt Neutrophil NETs in Ca
2026-05-28
This study introduces phenylboronic acid (PBA)-modified PAD4 inhibitors that selectively target tumor cells by exploiting sialic acid-mediated uptake. These compounds robustly inhibit tumor progression and metastasis in vivo by blocking the PAD4-H3cit-NETs pathway in neutrophils, offering a new paradigm for highly specific cancer therapeutics.
-
Neticonazole Hydrochloride: Imidazole Antifungal and Cancer
2026-05-27
Neticonazole Hydrochloride is an imidazole antifungal with validated efficacy against cutaneous candidiasis and emerging roles in colorectal cancer research. Its dual-action mechanism involves fungal cell membrane synthesis inhibition and exosome pathway suppression. Benchmarks confirm its clinical and preclinical relevance.
-
E-4031: Advancing hERG Potassium Channel Blocker Research
2026-05-27
E-4031, a selective hERG potassium channel blocker, is catalyzing a new era in 3D cardiac electrophysiology research by enabling precise proarrhythmic substrate modeling and robust QT interval analyses. With innovations like shell microelectrode arrays and organoid platforms, researchers can now probe arrhythmogenic risk and drug safety with unprecedented spatial and temporal resolution.
-
Puerarin Drives Osteogenic Differentiation via the Nitric Ox
2026-05-26
This study reveals that puerarin enhances the osteogenic potential of rat dental follicle cells by activating the nitric oxide signaling pathway. The results offer mechanistic insight into periodontal regeneration strategies and highlight key molecular markers modulated by puerarin.